title: Fetal safety of letrozole and clomiphene citrate for ovulation induction.
authors: Toronto Centre for Advancing Reproduction Technology, Toronto ON, Canada.
authors: Rachel
authors: R
authors: Forman
authors: Simmerpal
authors: S
authors: Gill
authors: Myla
authors: M
authors: Moretti
authors: Togas
authors: T
authors: Tulandi
authors: Gideon
authors: G
authors: Koren
authors: Robert
authors: R
authors: Casper
mesh_terms: D000014:Abnormalities, Drug-Induced / Q000209:etiology*; D000328:Adult; D047072:Aromatase Inhibitors / Q000009:adverse effects*; D001724:Birth Weight / Q000187:drug effects; D002996:Clomiphene / Q000009:adverse effects*; D005260:Female; D005300:Fertility Agents, Female / Q000009:adverse effects*; D005333:Fetus / Q000002:abnormalities / Q000187:drug effects; D005865:Gestational Age; D006801:Humans; D000077289:Letrozole; D009570:Nitriles / Q000009:adverse effects*; D010062:Ovulation Induction / Q000379:methods; D011247:Pregnancy; D011256:Pregnancy Outcome; D012189:Retrospective Studies; D014230:Triazoles / Q000009:adverse effects*
chemical_list: D047072:Aromatase Inhibitors; D005300:Fertility Agents, Female; D009570:Nitriles; D014230:Triazoles; D002996:Clomiphene; D000077289:Letrozole